175 related articles for article (PubMed ID: 23512314)
1. Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.
Henson CC; Davidson SE; Ang Y; Babbs C; Crampton J; Kelly M; Lal S; Limdi JK; Whatley G; Swindell R; Makin W; McLaughlin J
Support Care Cancer; 2013 Aug; 21(8):2255-65. PubMed ID: 23512314
[TBL] [Abstract][Full Text] [Related]
2. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
Khalid U; McGough C; Hackett C; Blake P; Harrington KJ; Khoo VS; Tait D; Norman AR; Andreyev HJ
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1432-41. PubMed ID: 16580497
[TBL] [Abstract][Full Text] [Related]
3. A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.
Olopade FA; Norman A; Blake P; Dearnaley DP; Harrington KJ; Khoo V; Tait D; Hackett C; Andreyev HJ
Br J Cancer; 2005 May; 92(9):1663-70. PubMed ID: 15856043
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial.
Glover M; Smerdon GR; Andreyev HJ; Benton BE; Bothma P; Firth O; Gothard L; Harrison J; Ignatescu M; Laden G; Martin S; Maynard L; McCann D; Penny CEL; Phillips S; Sharp G; Yarnold J
Lancet Oncol; 2016 Feb; 17(2):224-233. PubMed ID: 26703894
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?
Andreyev HJ; Vlavianos P; Blake P; Dearnaley D; Norman AR; Tait D
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1464-71. PubMed ID: 15927411
[TBL] [Abstract][Full Text] [Related]
6. The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy.
Gillespie C; Goode C; Hackett C; Andreyev HJ
Aliment Pharmacol Ther; 2007 Aug; 26(4):555-63. PubMed ID: 17661759
[TBL] [Abstract][Full Text] [Related]
7. Predicting late effects of pelvic radiotherapy: is there a better approach?
Wedlake LJ; Thomas K; Lalji A; Blake P; Khoo VS; Tait D; Andreyev HJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1163-70. PubMed ID: 20231077
[TBL] [Abstract][Full Text] [Related]
8. A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences.
Muls A; Taylor A; Lalondrelle S; Kabir M; Norton C; Hart A; Andreyev HJ
Support Care Cancer; 2020 Oct; 28(10):4881-4889. PubMed ID: 31997018
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy.
White KL; Henson CC; Hann M; Eden M; Burden ST; Lal S; Davidson SE; McLaughlin JT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32771983
[TBL] [Abstract][Full Text] [Related]
11. The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.
Andreyev HJN; Lalji A; Mohammed K; Muls ACG; Watkins D; Rao S; Starling N; Chau I; Cruse S; Pitkaaho V; Matthews J; Caley L; Pittordou V; Adams C; Wedlake L
Support Care Cancer; 2021 Mar; 29(3):1443-1453. PubMed ID: 32676853
[TBL] [Abstract][Full Text] [Related]
12. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.
Andreyev HJ; Davidson SE; Gillespie C; Allum WH; Swarbrick E; ; ; ;
Gut; 2012 Feb; 61(2):179-92. PubMed ID: 22057051
[TBL] [Abstract][Full Text] [Related]
13. The Three-item ALERT-B Questionnaire Provides a Validated Screening Tool to Detect Chronic Gastrointestinal Symptoms after Pelvic Radiotherapy in Cancer Survivors.
Taylor S; Byrne A; Adams R; Turner J; Hanna L; Staffurth J; Farnell D; Sivell S; Nelson A; Green J
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e139-e147. PubMed ID: 27369458
[TBL] [Abstract][Full Text] [Related]
14. Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial.
Andreyev HJ; Benton BE; Lalji A; Norton C; Mohammed K; Gage H; Pennert K; Lindsay JO
Lancet; 2013 Dec; 382(9910):2084-92. PubMed ID: 24067488
[TBL] [Abstract][Full Text] [Related]
15. How patients manage gastrointestinal symptoms after pelvic radiotherapy.
Gami B; Harrington K; Blake P; Dearnaley D; Tait D; Davies J; Norman AR; Andreyev HJ
Aliment Pharmacol Ther; 2003 Nov; 18(10):987-94. PubMed ID: 14616164
[TBL] [Abstract][Full Text] [Related]
16. Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1.
Brown LC; Atherton PJ; Neben-Wittich MA; Wender DB; Behrens RJ; Kozelsky TF; Loprinzi CL; Haddock MG; Martenson JA
Support Care Cancer; 2013 Oct; 21(10):2869-77. PubMed ID: 23748483
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from treating bile acid malabsorption using a multidisciplinary approach.
Gupta A; Muls AC; Lalji A; Thomas K; Watson L; Shaw C; Andreyev HJ
Support Care Cancer; 2015 Oct; 23(10):2881-90. PubMed ID: 25693765
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Dietary Fiber in Managing Gastrointestinal Toxicity Symptoms in Patients with Gynecologic Cancers undergoing Pelvic Radiotherapy: A Systematic Review.
Croisier E; Brown T; Bauer J
J Acad Nutr Diet; 2021 Feb; 121(2):261-277.e2. PubMed ID: 33127328
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.
Wedlake LJ; Silia F; Benton B; Lalji A; Thomas K; Dearnaley DP; Blake P; Tait D; Khoo VS; Andreyev HJ
Eur J Cancer; 2012 Sep; 48(14):2117-24. PubMed ID: 22386574
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation and treatment of chronic bowel symptoms following cancer in the colon and pelvic organs.
Larsen HM; Borre M; Christensen P; Mohr Drewes A; Laurberg S; Krogh K; Fassov J
Acta Oncol; 2019 May; 58(5):776-781. PubMed ID: 30698052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
